Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» drug approvals
drug approvals
Daiichi, AstraZeneca breast cancer drug joins bumper crop of early FDA approvals
BioPharma Dive
Fri, 12/20/19 - 08:19 pm
Daiichi Sankyo
AstraZeneca
FDA
drug approvals
breast cancer
trastuzumab deruxtecan
FDA survey finds Americans don’t really understand drug approvals
Endpoints
Tue, 12/17/19 - 09:20 pm
FDA
drug approvals
5 New Drug Approvals the FDA Gave Top Priority
Motley Fool
Sat, 11/30/19 - 11:22 pm
FDA
drug approvals
Global Blood Therapeutics
Oxbryta
Alnylam
Givlaari
BeiGene
Brukinsa
Vertex Pharmaceuticals
Before 2019 closes, the FDA has 3 key approval decisions to make
Biopharma Dive
Wed, 11/27/19 - 12:43 pm
Allergan
ubrogepant
migraines
Amarin
Vascepa
Intra-Cellular Therapeutics
lumateperone
schizophrenia
bipolar disorder
drug approvals
FDA
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
RAPS.org
Wed, 11/27/19 - 12:39 pm
FDA
Vertex Pharmaceuticals
Trikafta
Novartis
Adakveo
Alnylam
Givlaari
BeiGene
Brukinsa
Global Blood Therapeutics
Oxbryta
drug approvals
FDA generic approvals hit a new record, but the effort's not paying off yet
Fierce Pharma
Fri, 10/18/19 - 07:49 pm
FDA
generics
drug approvals
Another Record Year for Generic Drug Approvals but Questions on Competition Remain
RAPS.org
Wed, 10/16/19 - 06:59 pm
FDA
generics
drug approvals
generic approvals
2 Biotechs With Approaching Drug Approvals
Motley Fool
Sun, 10/13/19 - 11:30 pm
drug approvals
drug launches
FDA
voxelotor
Global Blood Therapeutics
Immunomedics
sacituzumab govitecan
Have FDA’s Generic Approvals Helped With Competition? Researchers Say Too Early to Tell
RAPS.org
Fri, 10/11/19 - 10:43 pm
FDA
generics
competition
drug approvals
Is FDA Becoming Too Lax With its Drug Approval Standards? Senior FDA Officials Discuss
RAPS.org
Mon, 10/7/19 - 05:29 pm
FDA
drug approvals
Update on FDA Approvals for 2019
Eye on FDA
Sun, 10/6/19 - 12:41 pm
FDA
drug approvals
Oncologists listen when the FDA speaks, even after a drug hits the market
Endpoints
Thu, 09/26/19 - 10:47 am
FDA
oncology
oncologists
drug approvals
bladder cancer
Evidence underpinning approval of new cancer drugs raises questions
Medical Express
Wed, 09/18/19 - 07:08 pm
Europe
cancer
oncology
drug approvals
bias
Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report
Fierce Pharma
Wed, 09/4/19 - 11:32 pm
cancer
drug approvals
FDA
One-Third of Pre-Approved Drugs Haven’t Completed FDA Approval Process
BioSpace
Wed, 08/28/19 - 10:41 pm
FDA
drug approvals
accelerated approvals
EMA and FDA Historically Agree on Just About Every New Drug Approval, but is That Slowly Changing?
RAPS.org
Fri, 08/16/19 - 12:57 pm
FDA
EMA
Europe
drug approvals
Four New Drugs are Around the Corner. Here’s What You Need to Know.
Xconomy
Thu, 08/15/19 - 11:39 pm
FDA
drug approvals
AbbVie
Upadacitinib
Exondys 51
Sarepta Therapeutics
Nabriva Therapeutics
lefamulin
Roche
Rozlytrek
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
drug approvals
FDA
AbbVie
JNJ
Novartis
Pfizer
Skyrizi
psoriasis
Vyndaqel
Zolgensma
SMA
Mayzent
multiple sclerosis
Balversa
metastatic bladder cancer
GAO Pushes FDA to Improve First Cycle Generic Approval Rate
RAPS.org
Fri, 08/9/19 - 07:41 pm
GAO
drug approvals
FDA
generics
Novel drug approvals head for a down year
EP Vantage
Fri, 07/19/19 - 10:48 am
FDA
drug approvals
novel drugs
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »